Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1992 1
1994 2
1996 1
2001 1
2002 1
2003 1
2006 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Characterization of a fluorescent substance P analog.
Tota MR, Daniel S, Sirotina A, Mazina KE, Fong TM, Longmore J, Strader CD. Tota MR, et al. Among authors: mazina ke. Biochemistry. 1994 Nov 8;33(44):13079-86. doi: 10.1021/bi00248a017. Biochemistry. 1994. PMID: 7524660
Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I.
Lobell RB, Liu D, Buser CA, Davide JP, DePuy E, Hamilton K, Koblan KS, Lee Y, Mosser S, Motzel SL, Abbruzzese JL, Fuchs CS, Rowinsky EK, Rubin EH, Sharma S, Deutsch PJ, Mazina KE, Morrison BW, Wildonger L, Yao SL, Kohl NE. Lobell RB, et al. Among authors: mazina ke. Mol Cancer Ther. 2002 Jul;1(9):747-58. Mol Cancer Ther. 2002. PMID: 12479371 Free article.
A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer.
Rubin EH, Agrawal NG, Friedman EJ, Scott P, Mazina KE, Sun L, Du L, Ricker JL, Frankel SR, Gottesdiener KM, Wagner JA, Iwamoto M. Rubin EH, et al. Among authors: mazina ke. Clin Cancer Res. 2006 Dec 1;12(23):7039-45. doi: 10.1158/1078-0432.CCR-06-1802. Clin Cancer Res. 2006. PMID: 17145826 Free article. Clinical Trial.
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page